Search the Newsreel

Creative Medical Technology (NASDAQ: CELZ) Q2 loss, cash rises to $8.7M

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) reported a Q2 2026 net loss of $1.5 million, an increase from $1.2 million a year prior, while its cash and equivalents rose to $8.7 million, primarily due to warrant exercises. The company is advancing several regenerative …

Creative Medical Technology Holdings Inc (CELZ) Stock News Today

Creative Medical Technology Holdings Shares Surge as Traders Appear to Latch Onto Earlier Pipeline Updates and a Tiny-float Setup

Creative Medical Technology Holdings (CMT.A) shares experienced a significant surge, reaching as high as $1.90, despite the absence of recent news from the company. The trading activity suggests that investors are reacting to previously released pipeline updates and the stock's small float, which can …

CELZ Stock Jumps As New Diabetes Patent Fuels Momentum

Creative Medical Technology Holdings Inc. (CELZ) stock jumped by 20% after the company received a U.S. patent for its exosome-based immunotherapy for Type 1 diabetes, tied to its MyeloCelz platform. This intellectual property win strengthens CELZ's long-term story and could support future licensing, though …

Creative Medical Technology Holdings Inc (CELZ) Earnings Forecast: Future EPS & Revenue Growth Estimates

Creative Medical Technology Holdings Inc (CELZ) has an earnings forecast score of 8.00 and an average price target of $20.00, according to one analyst. This target suggests a significant upside of +2946.92% from its current trading price. The company's EPS for the previous quarter …

Creative Medical Technology Stock Surges After Key Patent Win

Creative Medical Technology Holdings Inc. (NASDAQ: CELZ) shares surged over 104% after the company received a Notice of Allowance from the USPTO for a patent related to its cell-free exosome technology. This patent, titled "Suppression of Diabetes Using Exosomes From Stem Cell Programmed Myeloid …

Creative Medical receives patent allowance for diabetes exosome tech

Creative Medical Technology Holdings Inc. (NASDAQ:CELZ) announced it received a Notice of Allowance from the USPTO for a patent covering the use of exosomes from stem cell-programmed myeloid cells to suppress diabetes. This technology, part of their MyeloCel

CELZ Stock Whipsaws As Traders Focus On Cash And Charts

Creative Medical Technology Holdings Inc. (CELZ) stock is experiencing significant volatility, attracting short-term momentum traders and scalpers. Despite very low revenue and substantial operating losses, the company holds $5.7 million in cash and no debt, providing a lifeline. Traders are focused on price action …

Exosome application gets U.S. allowance to target Type 1 diabetes autoimmunity

Creative Medical Technology Holdings (NASDAQ: CELZ) has received a U.S. patent allowance for an exosome-based immunotherapy targeting Type 1 diabetes. This patent strengthens its intellectual property across its MyeloCelz™, CELZ-101, and CELZ-201 diabetes platforms, covering the use of exosomes to suppress autoimmune destruction of …

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. SEC Filing (Aug 3, 2026)

This article reports on an SEC filing by Creative Medical Technology Holdings, Inc. (CELZ) on August 3, 2026, announcing the effectiveness of their S-3 Shelf Registration Statement. The filing was accepted by SEC EDGAR at 6:13 AM on the same day, with an effectiveness …

Creative Medical Technology Holdings Inc (CELZ) Valuation: PE, PB & Fair Value Analysis

Creative Medical Technology Holdings Inc (CELZ) currently has a valuation score of 7.55, ranking it 160 out of 385 in the Biotechnology & Medical Research industry. Its P/E ratio stands at -0.32, which is 0.00% below its recent high and -456.42% above its recent …

Creative Medical Technology Holdings Inc

This article provides a technical analysis of Creative Medical Technology Holdings Inc (CELZ), detailing its price momentum score, support and resistance levels, and various technical indicators and moving averages. The analysis indicates the stock is currently trading between identified support and resistance levels, suitable …

Creative Medical Technology Holdings Inc (CELZ) Cash Flow

This article provides a detailed cash flow statement for Creative Medical Technology Holdings Inc (CELZ), presenting quarterly and annual financial data spanning several years. It includes operating, investing, and financing cash flows, along with free cash flow, to help evaluate the company's financial health. …

Creative Medical Technology Holdings Inc (CELZ) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Creative Medical Technology Holdings Inc (CELZ), listing major shareholders and their proportionate holdings, including Geode Capital Management, L.L.C., Creative Medical Health, Inc., and Vanguard Capital Management, LLC. It also provides a breakdown of shareholder types, such as …

Creative Medical Technology Holdings Inc (CELZ) Financial Health: Profitability & Balance Sheet Analysis

Creative Medical Technology Holdings Inc (CELZ) currently holds a financial score of 7.79, placing it 83rd out of 386 in the Biotechnology & Medical Research industry, indicating a robust financial status despite low operating efficiency. The company reported a significant year-over-year revenue decrease of …

Form S-3 Creative Medical Technology Holdings Inc For: 24 July By Investing.com

This article announces that Creative Medical Technology Holdings Inc. filed a Form S-3 on July 24. The brief piece, published by Investing.com, indicates the filing relates to the company's financial activities.

Creative Medical Technology (NASDAQ: CELZ) files S-3 for 5.58M warrant-share resale

Creative Medical Technology Holdings, Inc. (CELZ) has filed an S-3 registration statement for the resale of up to 5,580,680 shares of common stock, which are issuable upon the exercise of warrants. The company will not receive proceeds from these resales, only from the exercise …

CELZ|Creative Medical Technology Holdings Inc|Price:0.810|Chg%:-0.000

Creative Medical Technology Holdings Inc (CELZ) has strong fundamentals and high growth potential, despite recent weak market performance. The stock is considered fairly valued within the Biotechnology & Medical Research industry, with high institutional ownership. Analysts rate it as a "Buy" with a significant …

Creative Medical Technology Holdings Inc (CELZ) Institutional Confidence

This article provides an overview of Creative Medical Technology Holdings Inc (CELZ) focusing on its institutional confidence score and shareholder activity. The company has a current stock price of $0.810. The score for institutional confidence is 3.00, and the article lists several institutional shareholders …

Creative Medical Technology Holdings Inc. (CELZ) Stock Price | Live Quotes & Charts | NASDAQ

This NASDAQ page provides live quotes and charts for Creative Medical Technology Holdings Inc. (CELZ) stock. As of the article's data, CELZ is trading at $0.8625, up 4.93%. The page indicates no analyst ratings or earnings information currently available for the company.